Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts

Annals of Allergy, Asthma, and Immunology, 05/25/2012

Allergen compatibilities can be compromised in some fungal–insect extract mixtures, contrary to current immunotherapy practice parameter recommendations. Separation of these products into different treatment vials may be required to produce stable mixtures for subcutaneous immunotherapy. Data from assay methodologies with distinct binding specificities provide a critical assessment of allergen activities in high–protease extract mixtures.

Print Article Summary Cat 2 CME Report